Following the publication of the Key Paper Evaluation by Paolo Troia-Cancio and David M Asmuth, ‘Lessons from maraviroc clinical trials’, published in the June 2011 issue of Expert Review of Anti-Infective Therapy (Expert Rev. Anti Infect. Ther. 9[6], 649–651 [2011]), it has been brought to our attention that the following sentence on page 650 was incorrectly printed as:
“More patients in the maraviroc arms reached viral loads less than 50 copies compared with those on placebo (46% for twice-daily maraviroc, 43% for once-daily maraviroc 29% for placebo).”
The correct sentence is shown below:
“More patients in the maraviroc arms reached viral loads less than 50 copies compared with those on placebo (46% for twice-daily maraviroc, 43% for once-daily maraviroc and 17% for placebo).”
The authors and editors of Expert Review of Anti-Infective Therapy would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.